Teva Pharma B.V., Netherlands - نتائج البحث

الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

ribavirin teva pharma b.v.

teva b.v. - ribavirin - hepatitis c, chronic - antivirals for systemic use - ribavirin teva pharma b.v. is indicated in combination with other medicinal products for the treatment ofchronic hepatitis c (chc) in adults (see sections 4.2, 4.4, and 5.1).ribavirin teva pharma b.v. is indicated in combination with other medicinal products for the treatment ofchronic hepatitis c (chc) for paediatric patients (children 3 years of age and older and adolescents) notpreviously treated and without liver decompensation (see sections 4.2, 4.4 and 5.1).

الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

pramipexole teva

teva pharma b.v. - pramipexole dihydrochloride monohydrate - parkinson disease - anti-parkinson drugs - pramipexole teva is indicated for treatment of the signs and symptoms of idiopathic parkinson's disease, alone (without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end-of-dose or 'on-off' fluctuations).pramipexole teva is indicated in adults for symptomatic treatment of moderate to severe idiopathic restless legs syndrome in doses up to 0.54 mg of base (0.75 mg of salt) (see section 4.2).